FDA Approves Tecelra as First Gene Therapy for Synovial Sarcoma
The T-cell receptor gene therapy is approved for adults with unresectable or metastatic synovial sarcoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.